Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization.
about
Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissueVascularisation of the central nervous systemA review of therapies for diabetic macular oedema and rationale for combination therapyBlockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eyeSuppression and regression of choroidal neovascularization by the multitargeted kinase inhibitor pazopanib.Identification of genes and pathways involved in retinal neovascularization by microarray analysis of two animal models of retinal angiogenesisDigoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization.Effects of laser photocoagulation on serum angiopoietin-1, angiopoietin-2, angiopoietin-1/angiopoietin-2 ratio, and soluble angiopoietin receptor Tie-2 levels in type 2 diabetic patients with proliferative diabetic retinopathy.Notch3 is critical for proper angiogenesis and mural cell investment.Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculatureAnalysis of candidate genes for macular telangiectasia type 2Tie2-dependent neovascularization of the ischemic hindlimb is mediated by angiopoietin-2.A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathySugar creates a sticky business: round up the usual suspects.Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietinEssential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina.Molecular pathogenesis of retinal and choroidal vascular diseases.Defective retinal vascular endothelial cell development as a consequence of impaired integrin αVβ8-mediated activation of transforming growth factor-β.Role of the retinal vascular endothelial cell in ocular diseaseLife is a pattern: vascular assembly within the embryo.Ocular neovascularization.Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesisThe HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization.Therapeutic targeting of the angiopoietin-TIE pathway.Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells.Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated With Ozurdex TrialApoptotic effect of mtrix metalloproteinases 9 in the development of diabetic retinopathy.Role of Angiopoietins and Tie-2 in Diabetic Retinopathy.Wnt signaling mediates pathological vascular growth in proliferative retinopathyAngiopoietin/Tek interactions regulate mmp-9 expression and retinal neovascularization.Retinal and choroidal angiogenesis: a review of new targets.Angiopoietin-4-dependent venous maturation and fluid drainage in the peripheral retina
P2860
Q24807279-679ACDEA-5F2C-4E65-91E4-D3D861BF0EF2Q26801786-F86C7AA1-6917-47A2-819A-DEA007700804Q27008325-88BC69C6-44F9-4801-A989-8C769289AC51Q28743307-B23252BF-0DD6-4589-8D19-0CF54F3B9248Q33429798-5942B01A-5179-4048-BEDE-B903203D2ACFQ33845347-A385BBCB-A11B-4A8C-852C-AE01A31F63D2Q33868764-019D29A8-A0B8-4E23-89A8-27512AF28224Q34063056-D2F5710D-B62C-4CA5-8439-BA95450CD99CQ34168399-ABAF36A9-E3CD-44A7-BBB0-06EBFBB63FB2Q34311551-6D2435C3-E596-4848-8289-B9B8E4B2CE96Q34410734-34C7D815-EC3F-48A7-A7E5-31FF9882767DQ34437834-8B4A1008-968F-4501-90B8-261A67433B26Q35027679-403E31DD-0847-4077-AE47-61A36EABC916Q35748024-006F0A62-B3EC-4E6F-AB78-D1544004A2C6Q35791973-B672B4F4-A023-4194-A27B-FCFBE71E6124Q35925633-5A470C0F-DBBC-4BDE-B4FB-8BED17244E6BQ36296789-6BDD43BA-9005-4A49-B292-654162634682Q36626902-AB21A909-1651-4C05-A3EE-0B7CE61D5058Q36919959-33C5753E-30B2-4E2D-A969-3E55F515EF34Q37971729-43889D4F-CF50-4CDF-B7C5-0D6D52DF7B19Q38074872-44C7A37B-3FD1-4860-A878-3F1E6011FFCDQ38108833-C0A74FFA-8FF6-444C-8CDC-D5EF37A5C659Q38753745-470B1F35-9164-4D30-9490-7002B2B1A95FQ39076235-87D36270-494C-4C3D-A5F9-2DA5B8234EE6Q39321127-40B8B9E7-2AF7-4EB7-A393-B9B89A13D028Q39740070-D0F2B93F-DB91-4D28-861E-C920D10A0B24Q41059388-E75BC1E8-F647-4F76-92FF-38366F21230CQ42107211-637F2DC5-0F26-439E-89CD-7EC63B9C4351Q42364223-E8B68926-3562-43BC-867F-4654E8E52BE6Q42546329-C32ADB6A-1FB6-479C-BA77-BEC8157CF60EQ44654332-3ACFC60B-49FC-4070-9176-6BEE39AC764BQ53098522-6085DEC0-B70B-461E-9685-6EBB60214B84Q59126431-81F15D71-D142-4A4D-A5FC-9C0068410DFD
P2860
Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Angiopoietin 2 expression in t ...... pathologic neovascularization.
@ast
Angiopoietin 2 expression in t ...... pathologic neovascularization.
@en
type
label
Angiopoietin 2 expression in t ...... pathologic neovascularization.
@ast
Angiopoietin 2 expression in t ...... pathologic neovascularization.
@en
prefLabel
Angiopoietin 2 expression in t ...... pathologic neovascularization.
@ast
Angiopoietin 2 expression in t ...... pathologic neovascularization.
@en
P2093
P1476
Angiopoietin 2 expression in t ...... pathologic neovascularization.
@en
P2093
Campochiaro PA
Hackett SF
Maisonpierre P
Strauss RW
Yancopoulos G
P304
P356
10.1002/1097-4652(200009)184:3<275::AID-JCP1>3.3.CO;2-Z
P577
2000-09-01T00:00:00Z